João Nuno Sereno de Almeida Moreira


AuthID: R-000-79J

Publications Awaiting Confirmation

21
TITLE: Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis
AUTHORS: Carvalho, LS; Goncalves, N; Fonseca, NA; Moreira, JN;
PUBLISHED: 2021, SOURCE: PHARMACEUTICALS, VOLUME: 14, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 34
IN MY: ORCID
22
TITLE: GMP-grade nanoparticle targeted to nucleolin downregulates tumor molecular signature, blocking growth and invasion, at low systemic exposure  Full Text
AUTHORS: Fonseca, NA; Gregorio, AC; Mendes, VM; Lopes, R; Abreu, T; Goncalves, N; Manadas, B; Lacerda, M; Figueiredo, P; Pereira, M; Gaspar, M; Colelli, F; Pesce, D; Signorino, G; Focareta, L; Fucci, A; Cardile, F; Pisano, C; Cruz, T; Almeida, L; Moura, V; Simoes, S; Moreira, JN; ...More
PUBLISHED: 2021, SOURCE: NANO TODAY, VOLUME: 37
INDEXED IN: Scopus WOS CrossRef: 17
IN MY: ORCID
23
TITLE: In Vitro and In Vivo Tumor Models for the Evaluation of Anticancer Nanoparticles
AUTHORS: Abreu, TR; Biscaia, M; Goncalves, N; Fonseca, NA; Moreira, JN;
PUBLISHED: 2021, SOURCE: BIO-NANOMEDICINE FOR CANCER THERAPY, VOLUME: 1295
INDEXED IN: Scopus WOS CrossRef: 8
IN MY: ORCID
24
TITLE: Modelling the impact of nucleolin expression level on the activity of F3 peptide-targeted pH-sensitive pegylated liposomes containing doxorubicin
AUTHORS: Lopes, R; Shi, K; Fonseca, NA; Gama, A; Ramalho, JS; Almeida, L; Moura, V; Simoes, S; Tidor, B; Moreira, JN;
PUBLISHED: 2021, SOURCE: DRUG DELIVERY AND TRANSLATIONAL RESEARCH, VOLUME: 12, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
25
TITLE: Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
AUTHORS: Brignole, C; Bensa, V; Fonseca, NA; Del Zotto, G; Bruno, S; Cruz, AF; Malaguti, F; Carlini, B; Morandi, F; Calarco, E; Perri, P; Moura, V; Emionite, L; Cilli, M; De Leonardis, F; Tondo, A; Amoroso, L; Conte, M; Garaventa, A; Sementa, AR; Corrias, MV; Ponzoni, M; Moreira, JN; Pastorino, F; ...More
PUBLISHED: 2021, SOURCE: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, VOLUME: 40, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 30
IN MY: ORCID
26
TITLE: The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway  Full Text
AUTHORS: Cruz, AF; Caleiras, MB; Fonseca, NA; Goncalves, N; Mendes, VM; Sampaio, SF; Moura, V; Melo, JB; Almeida, RD; Manadas, B; Simoes, S; Moreira, JN;
PUBLISHED: 2021, SOURCE: CANCERS, VOLUME: 13, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef: 8
IN MY: ORCID
27
TITLE: In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)  Full Text
AUTHORS: Costa, CP; Barreiro, S; Moreira, JN; Silva, R; Almeida, H; Lobo, JMS; Silva, AC ;
PUBLISHED: 2021, SOURCE: PHARMACEUTICALS, VOLUME: 14, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 37
IN MY: ORCID
28
TITLE: The Role of Natural Killer Cells in Soft Tissue Sarcoma: Prospects for Immunotherapy  Full Text
AUTHORS: Fortes Andrade, T; Almeida, JS; Sousa, LM; Santos Rosa, M; Freitas-Tavares, Paulo ; Casanova, JM ; Rodrigues Santos, P;
PUBLISHED: 2021, SOURCE: CANCERS, VOLUME: 13, ISSUE: 15
INDEXED IN: WOS
29
TITLE: Current challenges and emerging opportunities of CAR-T cell therapies
AUTHORS: Abreu, TR; Fonseca, NA; Goncalves, N; Moreira, JN;
PUBLISHED: 2020, SOURCE: JOURNAL OF CONTROLLED RELEASE, VOLUME: 319
INDEXED IN: Scopus WOS CrossRef: 81
IN MY: ORCID
30
TITLE: Insights on the Formulation of Recombinant Proteins
AUTHORS: Ribeiro, R; Abreu, TR; Silva, AC ; Goncalves, J; Moreira, JN;
PUBLISHED: 2020, SOURCE: CURRENT APPLICATIONS OF PHARMACEUTICAL BIOTECHNOLOGY, VOLUME: 171
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
Page 3 of 12. Total results: 118.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service